المؤلفون: Rumiantseva IuV, Karachunskiĭ AI, Aleĭnikova OV, Fechina LG, Shamardina AV, Litvinov DV, Ponomareva NI, Boĭchenko EG, Dudkin SA, Streneva OV, Kondratchik KL, Mansurova EG, Minkina LM, Lapotentova ES, Iniushkina EV, Iudina NB, Pavlova GP, Zhukovskaia EV, Khlebnikova OP, Lagoĭko SN, Basharova EV, Denisov RE, Zlobina VD, Banshchikova ES, Aslanian KS, Kondakova EV, Tselousova EV, Miakova NV, Turobova TV, Ryskal' OV, Chipsanova NF, Varfolomeeva SR, Rumiantsev AG

المصدر: Terapevticheskii arkhiv [Ter Arkh] 2010; Vol. 82 (7), pp. 11-9.

نوع المنشور: Clinical Trial; English Abstract; Journal Article; Multicenter Study

بيانات الدورية: Publisher: ZAO 'Konsilium Medikum Country of Publication: Russia (Federation) NLM ID: 2984818R Publication Model: Print Cited Medium: Print ISSN: 0040-3660 (Print) Linking ISSN: 00403660 NLM ISO Abbreviation: Ter Arkh Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Combined Chemotherapy Protocols/*therapeutic use , Precursor Cell Lymphoblastic Leukemia-Lymphoma/*drug therapy, Adolescent ; Age Factors ; Antineoplastic Combined Chemotherapy Protocols/administration & dosage ; Child ; Child, Preschool ; Disease-Free Survival ; Dose-Response Relationship, Drug ; Drug Administration Schedule ; Female ; Humans ; Infant ; Male ; Precursor Cell Lymphoblastic Leukemia-Lymphoma/mortality ; Precursor Cell Lymphoblastic Leukemia-Lymphoma/prevention & control ; Recurrence ; Russia

المؤلفون: Karachunskiĭ AI, Miakova NV, Rumiantseva IuV, Timakov AM, Makhortykh TZh, Fechina LG, Shamardina AV, Dudkin SA, Lebedev VV, Varfolomeeva SR, Timofeeva VN, Herold R, Stakelberg A, Henze G, Rumiantsev AG

المصدر: Terapevticheskii arkhiv [Ter Arkh] 2007; Vol. 79 (7), pp. 19-26.

نوع المنشور: Journal Article; Multicenter Study; Randomized Controlled Trial

بيانات الدورية: Publisher: ZAO 'Konsilium Medikum Country of Publication: Russia (Federation) NLM ID: 2984818R Publication Model: Print Cited Medium: Print ISSN: 0040-3660 (Print) Linking ISSN: 00403660 NLM ISO Abbreviation: Ter Arkh Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Combined Chemotherapy Protocols/*adverse effects , Precursor Cell Lymphoblastic Leukemia-Lymphoma/*drug therapy, Adolescent ; Antineoplastic Combined Chemotherapy Protocols/economics ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Asparaginase/adverse effects ; Asparaginase/economics ; Asparaginase/therapeutic use ; Child ; Child, Preschool ; Cyclophosphamide/adverse effects ; Cyclophosphamide/economics ; Cyclophosphamide/therapeutic use ; Cytarabine/adverse effects ; Cytarabine/economics ; Cytarabine/therapeutic use ; Daunorubicin/adverse effects ; Daunorubicin/economics ; Daunorubicin/therapeutic use ; Female ; Humans ; Male ; Mercaptopurine/adverse effects ; Mercaptopurine/economics ; Mercaptopurine/therapeutic use ; Methotrexate/adverse effects ; Methotrexate/economics ; Methotrexate/therapeutic use ; Precursor Cell Lymphoblastic Leukemia-Lymphoma/mortality ; Prednisone/adverse effects ; Prednisone/economics ; Prednisone/therapeutic use ; Treatment Outcome ; Vincristine/adverse effects ; Vincristine/economics ; Vincristine/therapeutic use

SCR Protocol: AIEOP acute lymphoblastic leukemia protocol

عنوان ترانسليتريتد: Rezul'taty lecheniia ostrogo limfoblastnogo leĭkoza u deteĭ po protokolu Moskva-Berlin-91 v 1991-2000 gg.

المؤلفون: Miakova NV; Research Institute of Pediatric Hematology and Oncology, Ministry of Health of the RF, Russian Children's Clinical Hospital, Moscow., Hartmann R, Rudneva AE, Trubina NM, Fechina LG, Timakov AM, Shamardina AV, Lebedev VV, Varfolomeeva SR, Dudkin SD, Dyshlevaia ZM, Timofeeva VN, Rumiantsev AG, Henze H, Karachunskiĭ AI

المصدر: Voprosy onkologii [Vopr Onkol] 2002; Vol. 48 (3), pp. 340-6.

نوع المنشور: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial

بيانات الدورية: Publisher: Nauchno-issledovatelʹskiĭ institut onkologii im. N.N. Petrova Country of Publication: Russia (Federation) NLM ID: 0413775 Publication Model: Print Cited Medium: Print ISSN: 0507-3758 (Print) Linking ISSN: 05073758 NLM ISO Abbreviation: Vopr Onkol Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Combined Chemotherapy Protocols*, Precursor Cell Lymphoblastic Leukemia-Lymphoma/*drug therapy, Adolescent ; Antimetabolites, Antineoplastic/administration & dosage ; Antineoplastic Agents/administration & dosage ; Antineoplastic Agents, Hormonal/administration & dosage ; Antineoplastic Agents, Phytogenic/administration & dosage ; Asparaginase/administration & dosage ; Child ; Child, Preschool ; Cytarabine/administration & dosage ; Data Interpretation, Statistical ; Daunorubicin/administration & dosage ; Dexamethasone/administration & dosage ; Female ; Follow-Up Studies ; Humans ; Infant ; Male ; Mercaptopurine/administration & dosage ; Methotrexate/administration & dosage ; Moscow ; Precursor Cell Lymphoblastic Leukemia-Lymphoma/mortality ; Remission Induction ; Risk Factors ; Russia ; Survival Analysis ; Time Factors ; Vincristine/administration & dosage

عنوان ترانسليتريتد: Lechenie ostrogo limfoblastnogo leĭkoza u deteĭ po protokolu OLL-BFM-90m v Rossiĭskoĭ Federatsii i Respublike Belarus'.

المؤلفون: Miakova NV; Research Institute of Pediatric Hematology and Oncology, Ministry of Health of the RF, Russian Children's Clinical Hospital, Moscow., Aleĭnikova OV, Hartmann R, Rudneva AE, Trubina NM, Fechina LG, Timakov AM, Shamardina AV, Lebedev VV, Varfolomeeva SIu, Dudkin SD, Dyshlevaia ZM, Timofeeva VN, Rumiantsev AG, Henze H, Karachunskiĭ AI

المصدر: Voprosy onkologii [Vopr Onkol] 2002; Vol. 48 (3), pp. 347-51.

نوع المنشور: Clinical Trial; Comparative Study; English Abstract; Journal Article; Multicenter Study

بيانات الدورية: Publisher: Nauchno-issledovatelʹskiĭ institut onkologii im. N.N. Petrova Country of Publication: Russia (Federation) NLM ID: 0413775 Publication Model: Print Cited Medium: Print ISSN: 0507-3758 (Print) Linking ISSN: 05073758 NLM ISO Abbreviation: Vopr Onkol Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Combined Chemotherapy Protocols/*therapeutic use , Precursor Cell Lymphoblastic Leukemia-Lymphoma/*drug therapy, Adolescent ; Age Factors ; Antimetabolites, Antineoplastic/administration & dosage ; Chi-Square Distribution ; Child ; Child, Preschool ; Data Interpretation, Statistical ; Female ; Follow-Up Studies ; Humans ; Infant ; Infant, Newborn ; Leucovorin/administration & dosage ; Male ; Methotrexate/administration & dosage ; Precursor Cell Lymphoblastic Leukemia-Lymphoma/mortality ; Prognosis ; Republic of Belarus ; Risk Factors ; Russia ; Sex Factors ; Survival Analysis ; Time Factors

عنوان ترانسليتريتد: Lechenie ostrogo promielotsitarnogo leĭkoza u deteĭ all-transretinoevoĭ kislotoĭ.

المؤلفون: Maschan AA, Klebanova NG, Miakova NV, Tiganova OA, Timakov AM, Samochatova EV

المصدر: Gematologiia i transfuziologiia [Gematol Transfuziol] 1996 Mar-Apr; Vol. 41 (2), pp. 43-5.

نوع المنشور: Case Reports; Journal Article

بيانات الدورية: Publisher: Meditsina Country of Publication: Russia (Federation) NLM ID: 8301796 Publication Model: Print Cited Medium: Print ISSN: 0234-5730 (Print) Linking ISSN: 02345730 NLM ISO Abbreviation: Gematol Transfuziol Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents/*therapeutic use , Leukemia, Promyelocytic, Acute/*drug therapy , Tretinoin/*therapeutic use, Child ; Female ; Humans ; Male ; Recurrence ; Remission Induction/methods

عنوان ترانسليتريتد: Primenenie NAM-protokola v lechenii refrakternogo ostrogo nelimfoblastnogo leĭkoza [M5].

المؤلفون: Kondratchik KL, Chernov VM, Mazo AA, Miakova NV

المصدر: Gematologiia i transfuziologiia [Gematol Transfuziol] 1994 Mar-Apr; Vol. 39 (2), pp. 46-7.

نوع المنشور: Case Reports; Journal Article

بيانات الدورية: Publisher: Meditsina Country of Publication: Russia (Federation) NLM ID: 8301796 Publication Model: Print Cited Medium: Print ISSN: 0234-5730 (Print) Linking ISSN: 02345730 NLM ISO Abbreviation: Gematol Transfuziol Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Combined Chemotherapy Protocols/*therapeutic use , Leukemia, Myeloid, Acute/*drug therapy, Child ; Cytarabine/administration & dosage ; Female ; Humans ; Mitoxantrone/administration & dosage